ABAX Market Cap History
Below is a table of the ABAX market cap history going back to 2/5/2010:

Date ABAX Market Cap
2/5/2010508.75M
6/9/2010483.41M
8/5/2010467.87M
11/5/2010568.24M
2/7/2011578.71M
6/9/2011658.95M
8/4/2011492.16M
11/4/2011601.32M
2/6/2012624.67M
6/11/2012715.77M
8/6/2012818.06M
11/6/2012815.22M
2/6/2013966.08M
6/11/20131.02B
8/6/2013906.15M
11/8/2013785.05M
2/5/2014825.55M
5/27/2014946.60M
5/30/2014927.96M
8/6/20141.04B
11/6/20141.21B
2/5/20151.33B
5/27/20151.21B
5/29/20151.20B
8/6/20151.11B
11/6/20151.20B
2/8/2016905.68M
5/26/20161.01B
8/8/20161.10B
11/8/20161.09B
2/7/20171.14B
5/26/20171.12B
8/7/20171.05B
11/7/20171.04B
2/7/20181.48B
5/25/20181.90B

Also see: ABAX Shares Outstanding History
and ABAX YTD Return
ABAX Historical Market Cap:
+17.19% CAGR
ABAX Historical Market Cap: +17.19% CAGR

Mouse over chart for data details
2/5/2010 ...5/25/2018
Abaxis is engaged in developing, manufacturing and marketing portable blood analysis systems for use in the human or veterinary patient-care to provide clinicians with blood constituent measurements. Co. has two business segments: medical market, with products manufactured and sold in this segment primarily consist of Piccolo chemistry analyzers and medical reagent discs; and veterinary market, with product offerings that include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests. We show 36 historical shares outstanding datapoints in our ABAX shares outstanding history coverage, used to compute ABAX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ABAX market cap history over the course of time is important for investors interested in comparing ABAX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ABAX versus a peer is one thing; comparing ABAX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ABAX can fluctuate over the course of history. With this page we aim to empower investors researching ABAX by allowing them to research the ABAX market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ABAX:
ABAX SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Abaxis (ABAX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ABBV Market Cap History
ABC Market Cap History
ABEO Market Cap History
ABIO Market Cap History
ABMD Market Cap History
ABT Market Cap History
ACAD Market Cap History
ACER Market Cap History
ACET Market Cap History
ACHC Market Cap History
More Healthcare companies »

 

ABAX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.